Published in Healthcare Mergers, Acquisitions and Ventures Week, February 3rd, 2007
"We are pleased to see that the first of our core technology patents is going to be granted internationally," said Richard Garr, Neuralstem's president and CEO. "This patent, already issued in the United States, covers the basic technology for creating human neural stem cells and also their composition of matter."
Neuralstem intends to develop and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.